James McCloskey
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 50
- Acute Myeloid Leukemia Research 31
- Chronic Myeloid Leukemia Treatments 25
- Multiple Myeloma Research and Treatments 7
- Genetics 25
- Chronic Lymphocytic Leukemia Research 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Co-authors
- Jamie Koprivnikar (16 shared papers)Hagop M. Kantarjian (7 shared papers)Stefan Faderl (5 shared papers)Michael R. Savona (6 shared papers)Catherine C. Smith (5 shared papers)Mark J. Levis (7 shared papers)Naval Daver (5 shared papers)Alexander E. Perl (5 shared papers)
- Journals
- Blood (29 papers)Journal of Clinical Oncology (14 papers)Cancer Medicine (2 papers)HemaSphere (2 papers)Blood Advances (2 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
James McCloskey
58 papers receiving 842 citations
James McCloskey's Hit Papers
Peers
Comparison fields: 5 of 77
- Hematology 496
- Genetics 129
- Oncology 165
- Molecular Biology 352
- Public Health, Environmental and Occupational Health 133
Countries citing papers authored by James McCloskey
This map shows the geographic impact of James McCloskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McCloskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McCloskey more than expected).
Fields of papers citing papers by James McCloskey
This network shows the impact of papers produced by James McCloskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McCloskey. The network helps show where James McCloskey may publish in the future.
Co-authors
The 25 scholars most cited alongside James McCloskey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 151 | |
| 2 | Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Hit paper breakdown → | 2022 | 132 |
| 3 | 2018 | 88 | |
| 4 | 2020 | 78 | |
| 5 | 2017 | 48 | |
| 6 | 2020 | 42 | |
| 7 | 2020 | 23 | |
| 8 | 2005 | 18 | |
| 9 | 2024 | 17 | |
| 10 | 2023 | 17 | |
| 11 | 2022 | 15 | |
| 12 | 2011 | 15 | |
| 13 | 2019 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2015 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2021 | 11 | |
| 18 | Safe and effective treatment of aggressive non-hodgkin lymphoma with rituximab and bendamustine in patients with severe liver impairment. | 2013 | 11 |
| 19 | 2022 | 10 | |
| 20 | 2016 | 9 |
About James McCloskey
James McCloskey is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Molecular Biology, having authored 69 papers that have together received 855 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (31 papers), Chronic Myeloid Leukemia Treatments (25 papers), Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (7 papers), Cancer Genomics and Diagnostics (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hematology (496 citations), Genetics (129 citations), Oncology (165 citations), Molecular Biology (352 citations) and Public Health, Environmental and Occupational Health (133 citations). James McCloskey has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Jamie Koprivnikar, Hagop M. Kantarjian, Stefan Faderl, Michael R. Savona, Catherine C. Smith, Mark J. Levis, Naval Daver, Alexander E. Perl, Guillermo Garcia‐Manero and Gary J. Schiller. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Medicine, HemaSphere and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.